CN108853249A - 一种治疗皮肤病的涂膜剂 - Google Patents
一种治疗皮肤病的涂膜剂 Download PDFInfo
- Publication number
- CN108853249A CN108853249A CN201811157811.7A CN201811157811A CN108853249A CN 108853249 A CN108853249 A CN 108853249A CN 201811157811 A CN201811157811 A CN 201811157811A CN 108853249 A CN108853249 A CN 108853249A
- Authority
- CN
- China
- Prior art keywords
- plastics
- root skin
- ethyl alcohol
- extract
- content concn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920003023 plastic Polymers 0.000 title claims abstract description 25
- 239000004033 plastic Substances 0.000 title claims abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 54
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 41
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 235000019441 ethanol Nutrition 0.000 claims abstract description 28
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 22
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 22
- 241000759264 Rhamnus crenata Species 0.000 claims abstract description 18
- 208000002474 Tinea Diseases 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 16
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 16
- 244000089698 Zanthoxylum simulans Species 0.000 claims abstract description 14
- 201000004624 Dermatitis Diseases 0.000 claims abstract description 13
- OTQQONDAQUGNHS-UHFFFAOYSA-N [N].C(CCCCCCCCCCC)(=O)O Chemical compound [N].C(CCCCCCCCCCC)(=O)O OTQQONDAQUGNHS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 10
- 201000009053 Neurodermatitis Diseases 0.000 claims abstract description 9
- 241000130764 Tinea Species 0.000 claims abstract description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 9
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 9
- 206010063409 Acarodermatitis Diseases 0.000 claims abstract description 8
- 241000447727 Scabies Species 0.000 claims abstract description 8
- 241000893966 Trichophyton verrucosum Species 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 208000005687 scabies Diseases 0.000 claims abstract description 8
- 208000010195 Onychomycosis Diseases 0.000 claims abstract description 7
- 208000007712 Tinea Versicolor Diseases 0.000 claims abstract description 7
- 201000010618 Tinea cruris Diseases 0.000 claims abstract description 7
- 206010056131 Tinea versicolour Diseases 0.000 claims abstract description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 7
- 201000005882 tinea unguium Diseases 0.000 claims abstract description 7
- 210000004243 sweat Anatomy 0.000 claims abstract description 6
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract description 5
- 206010000496 acne Diseases 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 40
- 239000000284 extract Substances 0.000 claims description 31
- 239000000706 filtrate Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 13
- 241001494496 Leersia Species 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 4
- 230000008020 evaporation Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000011812 mixed powder Substances 0.000 claims description 4
- 238000005057 refrigeration Methods 0.000 claims description 4
- 244000018633 Prunus armeniaca Species 0.000 claims description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 241000218628 Ginkgo Species 0.000 claims 4
- 239000003814 drug Substances 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 9
- 241000233866 Fungi Species 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 3
- 230000001139 anti-pruritic effect Effects 0.000 abstract description 3
- 239000003908 antipruritic agent Substances 0.000 abstract description 3
- 229960004756 ethanol Drugs 0.000 description 18
- 229940079593 drug Drugs 0.000 description 12
- 208000017520 skin disease Diseases 0.000 description 8
- 238000002386 leaching Methods 0.000 description 7
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000002683 foot Anatomy 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- -1 C15H12O3) Chemical compound 0.000 description 4
- 241000949456 Zanthoxylum Species 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- ZZBWSNKBZKPGAK-UHFFFAOYSA-N chrysophanol-9-anthrone Chemical compound C1=CC=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O ZZBWSNKBZKPGAK-UHFFFAOYSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- 244000147568 Laurus nobilis Species 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- 208000008350 Pruritus Vulvae Diseases 0.000 description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- 244000053095 fungal pathogen Species 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- TUGAUFMQYWZJAB-FPLPWBNLSA-N 5-[(8Z)-pentadec-8-enyl]resorcinol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC(O)=CC(O)=C1 TUGAUFMQYWZJAB-FPLPWBNLSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 229930063422 Bilobalide A Natural products 0.000 description 1
- SRLTUZDQBFYLQI-FPLPWBNLSA-N Bilobol Natural products Oc1c(CCCCCCC/C=C\CCCCCC)ccc(O)c1 SRLTUZDQBFYLQI-FPLPWBNLSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 244000237791 Chionanthus virginicus Species 0.000 description 1
- 235000015256 Chionanthus virginicus Nutrition 0.000 description 1
- 241000758719 Chloranthaceae Species 0.000 description 1
- 241001310034 Chloranthus fortunei Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000721570 Melaphis Species 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001516602 Schlechtendalia chinensis Species 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 241000032846 Zanthoxylum bungeanum Species 0.000 description 1
- 241001079064 Zanthoxylum schinifolium Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000004196 common wart Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 229930184727 ginkgolide Natural products 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- HUOOMAOYXQFIDQ-UHFFFAOYSA-N isoginkgetin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)OC)=C2O1 HUOOMAOYXQFIDQ-UHFFFAOYSA-N 0.000 description 1
- CGPVRBMMGYBFAC-UHFFFAOYSA-N isoginkgetin Natural products COc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4OC)C5=CC(=O)c6c(O)cc(O)cc6O5 CGPVRBMMGYBFAC-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明具体公开了一种治疗皮肤病的涂膜剂,属于中药制备领域。治疗皮肤病的涂膜剂,它是由每1000g涂膜剂中长叶冻绿100g,剪草50g,木鳖子根皮50g,银杏外种皮100g,银杏树根皮50g,蛇床子50g,五倍子30g,花椒20g,月桂酸氮
Description
技术领域
本发明属于中药制剂领域,具体涉及一种治疗皮肤病的涂膜剂。
背景技术
中医学认为,人体内有一些疾病可以通过皮肤反映出来,很多疾病是内脏疾病的外在表现,即皮肤发生的根本原因在于阴阳失调,血垢瘀阻、毒素累积所致。但,有些皮肤病则是因真菌、皮肤细菌感染等引起。总之,皮肤病是皮肤(包括毛发和甲)受到内外因素的影响后,其形态、结构和功能均发生变化,产生病理过程,并相应的产生各种临床先后表现。皮肤病也是严重影响人们健康的常见病症,常见的皮肤病有银屑病、湿疹、皮炎、神经性皮炎、寻常疣、过敏性红疹、疥疮、青春痘、手足癣、甲癣、花斑癣、体癣、股癣等,这些皮肤疾病经常困扰人们的幸福生活,困扰着人们的心灵和精神。精确完善的治疗能使人们充满对生活的热爱和自信。现有的中药治疗皮肤病,其配方均有单一型或局限性,或是药材组成配伍不合理,或因在加工或炮制的过程中对其有效成分提取不完整或者提取不合理、不到位,在一定程度上达不到深层治疗的效果,因而造成治疗不彻底容易复发。还有就现有的西药或中药在治疗皮肤病中不同程度的添加激素类或抗生素类药物,存在一定的毒副作用或容易产生抗体,还有部分药物达不到治疗和修复病变部位的目的。就目前针对皮肤病常用的水剂、乳膏、酊剂等疗效局限不理想,治愈率低、反复发作,尤其是一些常见的如皮炎、神经性皮炎、汗斑、手足癣、甲癣、花斑癣、体癣、股癣等药效不明显,不仅能给患者造成精神压力和负担,同时还给患者增加经济负担。
发明内容
针对现有技术存在的不足,本发明提供了一种治疗皮肤病的涂膜剂,有针对性的解决因各种细菌、真菌等造成的皮炎、神经性皮炎、痤疮、疥疮、手足癣、甲癣、花斑癣、体癣、股癣等的治疗问题,为了实现上述目的,本发明具体采用了以下技术方案:
一种治疗皮肤病的涂膜剂,其特征在于,它是由每1000g涂膜剂中含长叶冻绿100g,剪草50g,木鳖子根皮50g,银杏外种皮100g,银杏树根皮50g,蛇床子50g,五倍子30g,花椒20g,月桂酸氮酮30g,二甲基亚砜30g,羧甲基纤维素钠20g,聚乙烯吡咯烷酮100g和余量含量浓度为75%v/v的乙醇组成,按以下方法制得:分别将长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、花椒、经烘干、粉碎成42目粗粉,另将蛇床子、五倍子分别捣碎成粉备用,按配方量称取各药材粗粉,混合均匀,分别以药材混合粉重量的5倍、3倍、1倍的纯净水煎煮提取3次,煎煮时间分别为3h、2h、1h,合并3次煎煮液过滤,滤液蒸发溶剂使成浸膏,然后将浸膏以含量浓度为86%-96%v/v的乙醇溶解,搅拌,置于0℃-2℃条件下冷藏24h后,过滤,滤液蒸干溶剂得其提取物备用,取含量浓度为75%v/v的乙醇约600g,加入提取物,搅拌使其溶解,然后再依次加入月桂酸氮酮和二甲基亚砜,拌匀后,加入羧甲基纤维素钠和聚乙烯吡咯烷酮放置1h后,缓慢轻轻搅拌使其溶解均匀,再加入含量浓度为75%v/v的乙醇定容至1000g,充分均匀,定量分装于玻璃瓶内即可。
本发明一种治疗皮肤病的涂膜剂的制备方法,其特征包括如下步骤:
(1)分别将长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、花椒经烘干、粉碎成42目粗粉,另将蛇床子、五倍子分别捣碎成粉备用;
(2)称取长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、蛇床子、五倍子、花椒粗粉混合均匀,分别以药材混合粉重量5倍、3倍、1倍的纯净水煎煮提取3次,煎煮时间分别为3h、2h、1h,合并3次煎煮液过滤,滤液蒸发溶剂使成浸膏;
(3)将上述所得浸膏以含量浓度为86%-96%v/v的乙醇溶解,搅拌,置于0℃-2℃条件下冷藏24h后,过滤,滤液蒸干溶剂得提取物备用;
(4)取含量浓度为75%v/v的乙醇约600g,加入备用提取物,搅拌使其溶解,然后再依次加入月桂酸氮酮和二甲基亚砜,拌匀后,加入羧甲基纤维素钠和聚乙烯吡咯烷酮,放置1h后,缓慢轻轻搅拌使其溶解均匀,再加入含量浓度为75%v/v的乙醇定容至1000g,充分均匀;
(5)将充分均匀的溶液分装于30ml的玻璃瓶内密封即得。
本发明的一种治疗皮肤病的涂膜剂作为治疗皮炎、神经性皮炎、痤疮、疥疮、汗斑、手足癣、甲癣、花斑癣、体癣、股癣的用途。
长叶冻绿,为鼠李科鼠李属植物长叶冻绿Rhamnus crenatus Sieb.et Zucc.,以根入药。其根含蒽醌类化合物柯桠素(chrysarobin,C15H12O3)、大黄酚(chrysophanol,C15H10O4)等。性味苦、辛,平。具有清热利湿,杀虫止痒功能。外用治疥疮,顽癣,湿疹,脓胞疮。
剪草,为金粟兰科植物丝穗金粟兰Chloranthus fortunei(A.Gray)Solms-Lamb.的全草或根。性味辛、苦,性平。具有祛风活血,解毒消肿之功能。用于风湿痹痛,跌打损伤,疮疖癣疥,毒蛇咬伤。本发明采用的为剪草全草。
木鳖子根,为葫芦科苦瓜属植物木鳖子Momrolica cochinchinensis(Lour.)Spreng.的根。具有散结消肿,攻毒疗疮功能,适用于疮疡肿毒,乳痈,痔漏,干癣、秃疮。本发明采用的为其根皮。
银杏外种皮是银杏树种子(即银杏)硬壳外面的部分,俗称白果衣,银杏种子的皮分肉质的外种皮、骨质的中种皮和膜质的内种皮,本发明采用的银杏外种皮是银杏种子的肉质外种皮。科学家经研究发现外种皮含有大量的氢化白果酸、白果酚和白果醇,还含有银杏黄素、异银杏黄素和多糖类成分,还有微量的银杏内酯。其作用性质与环磷酰胺及地塞米松等相似。银杏外种皮的多糖类可增强细胞免疫功能,对体液免疫过程中B淋巴细胞的产生和抗体形成有作用。具文献报道,银杏外种皮中的醇类中间体,对22种临床常见致病性真菌的抑制有效率为81%;0.1%氢化白果酸抑制25种临床常见致病性真菌的有效率为92%。据报道,银杏酸有较强的杀菌和抑制作用,对于葡萄球菌、化脓性球菌、甚至对于其它真菌有抑制作用,用它治疗真菌感染的湿癣有显著的作用。对病毒引起的脓胞疮疹、扁平疣有较好的疗效。
银杏树根皮,据文献报道:银杏树根皮亦含有银杏、银杏叶、银杏外种皮的相同成分。银杏树根皮也含有白果内酯A、B、C、M(《全国中草药汇编》编写组,全国中药汇编,上册,1975年,9月,第1版,801页)。
蛇床子,为伞形科蛇床属植物蛇床Cnidium monnieri Cuss.的干燥成熟果实。性味辛、苦,温。具有燥湿祛风,杀虫止痒,温肾壮阳功能,适用于阴痒带下,湿疹瘙痒,湿痹腰痛,肾虚阳痿,宫冷不孕。
五倍子,学名Rhus chinensis Mill.,为同翅目蚜虫科的角倍蚜或倍蛋蚜雌虫寄生于漆树科植物“盐肤木”及其同属其他植物的嫩叶或叶柄,刺伤而生成一种囊状聚生物虫瘿,经烘焙干燥后所得。五倍子其性寒,味酸、涩,具有敛肺降火、涩肠止泻、敛汗止血、收湿敛疮等功效。用于肺虚止咳,便血痔血,痈肿疮毒,皮肤湿烂等症。
花椒,为芸香科花椒属植物青花椒Zanthoxylum schinifolium Sieb.et Zucc.及花椒Zanthoxylum bungeanum Maxim.的干燥成熟果皮。性味辛,温。具有温中止痛,杀虫止痒功能。适用于脘腹冷痛,呕吐,泄泻,虫积腹痛;外用于湿疹,阴痒。
月桂氮酮,别名月桂氮;阿佐恩;氮酮;1-十二烷基-氮杂-a-酮;1-十二烷基-氨杂环庚-a-酮;Azone。本品为无色透明的黏稠液体;几乎无臭,无味。本品在无水乙醇、醋酸乙酯、乙醚、苯及环已烷中极易溶解,本品比较稳定。本品为非极性透皮促进剂。其作用机理被认为是使角质软化,凝固组织蛋白,增强通透性,使药物透过皮肤屏障,提高局部或全身性血药浓度,提高制剂的生物利用度,从而获得更为理想的治疗目的。
二甲基亚砜(DMSO)为无色无臭透明油状的粘性液体,味微苦,比重1.009-1.1014,熔点18.45℃,沸点189-192℃。可与水、乙醇、丙酮等任意混合。本品为高极性溶媒,溶解范围很广,对水溶性、脂溶性及许多难溶于水、甘油、乙醇、丙二醇、脂肪油的药物,许多无机盐也能溶于其中,故有“万能溶媒”之称。二甲基亚砜在本发明中的应用,则对其药材中的有机成分具有很大的增溶效果。
本发明的有益效果
本发明的一种治疗皮肤病的涂膜剂以杀灭各种细菌和真菌为主,并兼顾杀虫止痒,对皮炎、神经性皮炎、痤疮、疥疮、汗斑、手足癣、甲癣、花斑癣、体癣、股癣等有显著疗效,制备成本低,可以减轻患者的经济负担。本发明治疗皮肤病的涂膜剂为纯中药配制,保持了天然的药物毒性小,疗效好的特点,疗效明确,由于本发明是将药物的提取成分制成一种外涂涂膜剂,可减少药物的流动性,涂于患处,易形成薄膜,使药物逐渐释放起到治疗作用,能够使所含药物均衡吸收产生疗效。从临床应用上看本发明涂膜剂使用方便,用药量小,且有较好的临床治疗效果,使用方便,患者普遍乐意接受,药物价格较低,能够显现出本发明治疗皮肤病的涂膜剂具有很好的应用前景。
具体实施方式
实施例1
(1)先分别将长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、花椒经烘干、粉碎成42目粗粉,另将蛇床子、五倍子分别捣碎成粉备用;
(2)称取长叶冻绿粗粉100g、剪草粗粉50g,木鳖子根皮粗粉50g、银杏外种皮粗粉100g、银杏树根皮粗粉50g、蛇床子粉50g、五倍子粉30g、花椒粉20g混合均匀,加入纯净水2250g,煎煮提取3h,过滤,滤液另器保存,滤渣再加入纯净水1350g,煎煮提取2h,滤取煎煮液另器保存,再将滤渣加入纯净水450g煎煮1h,滤取煎煮液,合并3次滤液,过滤,将滤液蒸发溶剂使成浸膏;
(3)将上述所得浸膏以含量浓度为86%v/v的乙醇溶解,充分搅拌后,置于2℃条件下冷藏24h后,过滤,滤液蒸干溶剂得提取物备用;
(4)取含量浓度为75%v/v的乙醇约600g,加入备用提取物,搅拌使溶解,然后再依次加入月桂酸氮酮30g和二甲基亚砜30g,拌匀后,加入羧甲基纤维素钠20g,聚乙烯吡咯烷酮100g,放置1h后,缓慢轻轻搅拌使其溶解均匀,再加入含量溶度为75%v/v的乙醇定容至1000g,充分均匀;
(5)将充分均匀的溶液分装于30ml的玻璃瓶内,旋盖、密封即得。
实施例2
(1)先分别将长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、花椒经烘干、粉碎成42目粗粉,另将蛇床子、五倍子分别捣碎成粉备用;
(2)称取长叶冻绿粗粉100g、剪草粗粉50g,木鳖子根皮粗粉50g、银杏外种皮粗粉100g、银杏树根皮粗粉50g、蛇床子粉50g、五倍子粉30g、花椒粉20g混合均匀,加入纯净水2250g,煎煮提取3h,过滤,滤液另器保存,滤渣再加入纯净水1350g,煎煮提取2h,滤取煎煮液另器保存,再将滤渣加入纯净水450g煎煮1h,滤取煎煮液,合并3次滤液,过滤,将滤液蒸发溶剂使成浸膏;
(3)将上述所得浸膏以含量浓度为96%v/v的乙醇溶解,充分搅拌后,置于0℃条件下冷藏24h后,过滤,滤液蒸干溶剂得提取物备用;
(4)取含量浓度为75%v/v的乙醇约600g,加入备用提取物,搅拌使溶解,然后再依次加入月桂酸氮酮30g和二甲基亚砜30g,拌匀后,加入羧甲基纤维素钠20g,聚乙烯吡咯烷酮100g,放置1h后,缓慢轻轻搅拌使其溶解均匀,再加入含量浓度为75%v/v的乙醇定容至1000g,充分均匀;
(5)将充分均匀的溶液分装于30ml的玻璃瓶内,旋盖、密封即得。
实施例3
(1)先分别将长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、花椒经烘干、粉碎成42目粗粉,另将蛇床子、五倍子分别捣碎成粉备用;
(2)称取长叶冻绿粗粉100g、剪草粗粉50g,木鳖子根皮粗粉50g、银杏外种皮粗粉100g、银杏树根皮粗粉50g、蛇床子粉50g、五倍子粉30g、花椒粉20g混合均匀,加入纯净水2250g,煎煮提取3h,过滤,滤液另器保存,滤渣再加入纯净水1350g,煎煮提取2h,滤取煎煮液另器保存,再将滤渣加入纯净水450g煎煮1h,滤取煎煮液,合并3次滤液,过滤,将滤液蒸发溶剂使成浸膏;
(3)将上述所得浸膏以含量浓度为90%v/v的乙醇溶解,充分搅拌后,置于1℃条件下冷藏24h后,过滤,滤液蒸干溶剂得提取物备用;
(4)取含量浓度为75%v/v的乙醇约600g,加入备用提取物,搅拌使溶解,然后再依次加入月桂酸氮酮30g和二甲基亚砜30g,拌匀后,加入羧甲基纤维素钠20g,聚乙烯吡咯烷酮100g,放置1h后,缓慢轻轻搅拌使其溶解均匀,再加入含量浓度为75%v/v的乙醇定容至1000g,充分均匀;
(5)将充分均匀的溶液分装于30ml的玻璃瓶内,旋盖、密封即得。
临床疗效:
采用本发明的涂膜剂涂于患处,治疗神经性皮炎36例,其中男性22例,女性14例,年龄15-62岁,平均26岁,病程1个月-12个月,经皮肤科诊断确诊为神经性皮炎,病灶局部涂药每天3次,15天为一疗程,结果1个疗程治愈14例,2个疗程治愈21例,其中1例无效而改用其他方法治疗。治愈35例病人,随访6个月均未见复发。
采用本发明的涂膜剂涂于患处治疗汗斑77例,用药外涂,一日3次,一周内均痊愈,治愈率100%。
采用本发明的涂膜剂涂于患处治疗足癣12例,用药外涂,一日3次,12例全部治愈,平均用药8天。
采用本发明的涂膜剂涂于患处治疗体癣7例,局部用药外涂,一日3次,7例全部治愈,平均用药6天。
以上病例在治疗过程中均未出现不良反应。
Claims (3)
1.一种治疗皮肤病的涂膜剂,其特征在于,它是由每1000g涂膜剂中含长叶冻绿100g,剪草50g,木鳖子根皮50g,银杏外种皮100g,银杏树根皮50g,蛇床子50g,五倍子30g,花椒20g,月桂酸氮酮30g,二甲基亚砜30g,羧甲基纤维素钠20g,聚乙烯吡咯烷酮100g和余量含量浓度为75%v/v的乙醇组成,按以下方法制得:分别将长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、花椒、经烘干、粉碎成42目粗粉,另将蛇床子、五倍子分别捣碎成粉备用,按配方量称取各药材粗粉,混合均匀,分别以药材混合粉重量的5倍、3倍、1倍的纯净水煎煮提取3次,煎煮时间分别为3h、2h、1h,合并3次煎煮液过滤,滤液蒸发溶剂使成浸膏,然后将浸膏以含量浓度为86%-96%v/v的乙醇溶解,搅拌,置于0℃-2℃条件下冷藏24h后,过滤,滤液蒸干溶剂得其提取物备用,取含量浓度为75%v/v的乙醇约600g,加入提取物,搅拌使其溶解,然后再依次加入月桂酸氮酮和二甲基亚砜,拌匀后,加入羧甲基纤维素钠和聚乙烯吡咯烷酮放置1h后,缓慢轻轻搅拌使其溶解均匀,再加入含量浓度为75%v/v的乙醇定容至1000g,充分均匀,定量分装于玻璃瓶内即可。
2.如权利要求1所述一种治疗皮肤病的涂膜剂的制备方法,其特征在于,包括如下步骤;
(1)分别将长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、花椒经烘干、粉碎成42目粗粉,另将蛇床子、五倍子分别捣碎成粉备用;
(2)称取长叶冻绿、剪草、木鳖子根皮、银杏外种皮、银杏树根皮、蛇床子、五倍子、花椒粗粉混合均匀,分别以药材混合粉重量5倍、3倍、1倍的纯净水煎煮提取3次,煎煮时间分别为3h、2h、1h,合并3次煎煮液过滤,滤液蒸发溶剂使成浸膏;
(3)将上述所得浸膏以含量浓度为86%-96%v/v的乙醇溶解,搅拌,置于0℃-2℃条件下冷藏24h后,过滤,滤液蒸干溶剂得提取物备用;
(4)取含量浓度为75%v/v的乙醇约600g,加入备用提取物,搅拌使其溶解,然后再依次加入月桂酸氮酮和二甲基亚砜,拌匀后,加入羧甲基纤维素钠和聚乙烯吡咯烷酮,放置1h后,缓慢轻轻搅拌使其溶解均匀,再加入含量浓度为75%v/v的乙醇定容至1000g,充分均匀;
(5)将充分均匀的溶液分装于30ml的玻璃瓶内密封即得。
3.根据权利要求1所述一种治疗皮肤病的涂膜剂作为治疗皮炎、神经性皮炎、痤疮、疥疮、汗斑、手足癣、甲癣、花斑癣、体癣、股癣的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811157811.7A CN108853249A (zh) | 2018-09-30 | 2018-09-30 | 一种治疗皮肤病的涂膜剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811157811.7A CN108853249A (zh) | 2018-09-30 | 2018-09-30 | 一种治疗皮肤病的涂膜剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108853249A true CN108853249A (zh) | 2018-11-23 |
Family
ID=64324914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811157811.7A Withdrawn CN108853249A (zh) | 2018-09-30 | 2018-09-30 | 一种治疗皮肤病的涂膜剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108853249A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024052756A1 (en) * | 2022-09-09 | 2024-03-14 | Crodarom | Use of an extract of sichuan pepper for a skin treatment and a composition suitable for this use. |
FR3139466A1 (fr) * | 2022-09-09 | 2024-03-15 | Crodarom | Utilisation d’un extrait de poivrier de Sichuan pour un traitement cutané et une composition adaptée à cette utilisation. |
-
2018
- 2018-09-30 CN CN201811157811.7A patent/CN108853249A/zh not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024052756A1 (en) * | 2022-09-09 | 2024-03-14 | Crodarom | Use of an extract of sichuan pepper for a skin treatment and a composition suitable for this use. |
FR3139466A1 (fr) * | 2022-09-09 | 2024-03-15 | Crodarom | Utilisation d’un extrait de poivrier de Sichuan pour un traitement cutané et une composition adaptée à cette utilisation. |
FR3139467A1 (fr) * | 2022-09-09 | 2024-03-15 | Crodarom | Utilisation d’un extrait de poivrier de Sichuan pour un traitement cutané et une composition adaptée à cette utilisation. |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101445010B1 (ko) | 소염, 부기제거, 진통에 사용되는 중국 생약 조성물, 그 제조 방법 및 용도 | |
CN108938800A (zh) | 一种治疗皮肤病涂液膜 | |
KR101052321B1 (ko) | 무좀 치료 조성물 | |
CN108853249A (zh) | 一种治疗皮肤病的涂膜剂 | |
CN104873446A (zh) | 一种含肉桂油的牙膏 | |
KR101052322B1 (ko) | 무좀 치료 조성물의 제조방법 | |
CN109010640A (zh) | 一种治疗皮肤病的外用药物及制备方法 | |
CN112546087A (zh) | 一种用于皮肤和口腔护理的药物组合物及其制备方法 | |
CN109010485A (zh) | 一种治疗皮肤病涂膜剂的制备方法 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN108992527A (zh) | 一种治疗皮肤病外用涂膜剂的制备方法 | |
CN109010483A (zh) | 一种治疗皮肤病的外用酒剂 | |
CN109010484A (zh) | 一种治疗皮肤病的外用药酒及制备方法 | |
CN108853248A (zh) | 一种治疗皮肤病药膏 | |
CN109010482A (zh) | 一种治疗皮肤病的外用药水及制备方法 | |
CN108837028A (zh) | 一种治疗皮肤病的软膏 | |
Rahman et al. | Trigonella foenum-graecum L | |
CN105663819A (zh) | 一种医治腋臭的外用中药制剂及制法 | |
CN109010481A (zh) | 一种治疗皮肤病药物及制备方法和制剂 | |
CN108836993A (zh) | 一种皮肤癣外用药及制备方法 | |
CN112773826A (zh) | 一种用于皮肤和口腔护理的药物组合物及其制备方法 | |
CN104784541B (zh) | 一种用于去除粉刺的中药药剂及其制备方法 | |
CN109528871A (zh) | 一种用于治疗肛周疾病的外用中药组合物 | |
CN113521150A (zh) | 一种治疗腋臭的组合物、药膏及其制作工艺 | |
CN114344398A (zh) | 一种消痔愈裂膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181123 |
|
WW01 | Invention patent application withdrawn after publication |